Skip to main content
Tech Funding News· Abhinaya Prabhu·· 5 days agoTop DealsAI Score62

Biomatter raises $18M Series A led by Astanor to build Vilnius enzyme lab

Biomatter lands $18M from Astanor and UVC Partners to build a Vilnius enzyme lab

AI Overview

Biomatter, a Lithuanian biotech using AI to design custom enzymes, raised $18M in an oversubscribed Series A led by Astanor.

Why it matters

The round shows how proprietary lab data, not just model architecture, is becoming the moat in AI enzyme design, with named pharma and industrial customers already using the output.

Source:Tech Funding News · techfundingnews.com

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing